Ribavirin and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribavirin (ribavirin) and Hydroxyurea (hydroxyurea). Common drug interactions include pancytopenia among females and parainfluenzae virus infection among males.

The phase IV clinical study analyzes what interactions people have when they take Ribavirin and Hydroxyurea. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.



On Jul, 29, 2026

18 people who take Ribavirin and Hydroxyurea together, and have interactions are studied.

Ribavirin and Hydroxyurea drug interactions.

What are the common drug interactions of Ribavirin and Hydroxyurea, by gender? *:

female:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

  1. Parainfluenzae virus infection
  2. Alanine aminotransferase increased
  3. Abdominal discomfort
  4. Blood calcium decreased
  5. Chest pain
  6. Dyspepsia (indigestion)
  7. Eructation (release of gas from the digestive tract)
  8. Essential thrombocythaemia (chronic blood cancer)
  9. Nausea (feeling of having an urge to vomit)
  10. Oesophageal discomfort (pain or burning feeling behind breast bone)

What are the common drug interactions of Ribavirin and Hydroxyurea, by age (0-1 to 60+)? *:

0-1:

  1. Parainfluenzae virus infection
  2. Enterococcal infection
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Serratia infection (bacterial infection)
  10. Stenotrophomonas infection

2-9:

n/a

10-19:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Respiratory syncytial virus infection (viral disease of respiratory system)

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Haemolytic anaemia (anaemia due to haemolysis)
  4. Parainfluenzae virus infection

30-39:

  1. Death

40-49:

  1. Fatigue (feeling of tiredness)
  2. Secondary hypogonadism (a male refers to a decrease in either of the two major functions of the testes: sperm production or testosterone production)
  3. Gynaecomastia (enlargement of the gland tissue of the male breast)
  4. Haemosiderosis (general increase in tissue iron stores without associated tissue damage)
  5. Libido decreased (loss of interest in sex)
  6. Primary hypogonadism (decrease in one or both of the two major functions of the testes)
  7. Serum ferritin increased

50-59:

n/a

60+:

  1. Abdominal discomfort
  2. Blood calcium decreased
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  5. Chest pain
  6. Dyspepsia (indigestion)
  7. Eructation (release of gas from the digestive tract)
  8. Essential thrombocythaemia (chronic blood cancer)
  9. Nausea (feeling of having an urge to vomit)
  10. Oesophageal discomfort (pain or burning feeling behind breast bone)

What are the existing conditions these people have? *

  1. Parainfluenzae Virus Infection: 6 people, 33.33%
  2. Immunodeficiency Disorders: 4 people, 22.22%
  3. Rhinovirus Infection: 3 people, 16.67%
  4. Bone Marrow Conditioning Regimen: 3 people, 16.67%
  5. Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 3 people, 16.67%
  6. Viraemia (presence of a virus in the blood stream): 2 people, 11.11%
  7. Adenovirus Infection: 1 person, 5.56%
  8. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.56%
  9. Congo-Crimean Haemorrhagic Fever (tick-borne viral disease with bleeding): 1 person, 5.56%
  10. Enterovirus Infection: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ribavirin and Hydroxyurea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribavirin and Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and hydroxyurea (the active ingredients of Ribavirin and Hydroxyurea, respectively), and Ribavirin and Hydroxyurea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: